Xenitra与知名非处方药企签署1200万澳元供货协议

投资观察
Jul 27

据路透社7月27日消息,Xenitra Limited宣布达成一项价值1200万澳元的供货协议,合作方是一家领先的非处方药(OTC)制药企业。

公司表示,已与康盛股份(Zhe Jiang Kangsheng Co., Ltd.)签署了一份为期三年的药品采购框架协议。所有金额均以澳元计。

Xenitra预计,首批商业订单将在本季度内启动执行,标志着双方合作正式进入实质性阶段。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10